Cargando…
Reactive infectious mucocutaneous eruption following COVID-19 infection in vaccinated patients
Autores principales: | Aw, Michael, Gresham, Louise, Spurr, Alison, Gavigan, Genevieve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617667/ https://www.ncbi.nlm.nih.gov/pubmed/36340859 http://dx.doi.org/10.1016/j.jdcr.2022.10.018 |
Ejemplares similares
-
Clinical and microbiological characteristics of reactive infectious mucocutaneous eruption: A case series of 5 patients
por: Vassallo, Camilla, et al.
Publicado: (2021) -
Recurrent Mycoplasma pneumoniae–associated reactive infectious mucocutaneous eruption responsive to systemic steroids: A case series
por: Maredia, Hasina, et al.
Publicado: (2021) -
Reactive infectious mucocutaneous eruption in children diagnosed with COVID‐19
por: Bowe, Stephanie, et al.
Publicado: (2021) -
Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2
por: Ryder, C. Yoonhee, et al.
Publicado: (2021) -
Evolving mucocutaneous eruptions following chemotherapy
por: Chen, Ailynna, et al.
Publicado: (2022)